Skip to main content
SpringerLink
Log in

Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Neurotrophic factors, like e.g. nerve growth factor (NGF), neurotrophin 3 (NT-3) or brain-derived neurotrophic factor (BDNF) promote the survival and function of neurones in the peripheral and central nervous system. Dopamine or other biogenic amines induce the biosynthesis of neurotrophic factors in glial and neuronal cells. Therefore inhibition of enzymes, like the extraneuronal and neuronal located MAO or the predominantly glial situated COMT, which both metabolize catecholamines, may induce an increased biosynthesis of neurotrophic factors. Due to clinical studies especially MAO-B-inhibitors appear to slow the progression of neurological deficits in Parkinson's disease and the cognitive decline in Alzheimer's disease. On the one hand inhibition of COMT alone may also slow the metabolisation of biogenic amines in glial cells and may consequently induce synthesis of neurotrophic factors in glial cells. But on the other hand in vivo and in vitro studies show, that COMT-inhibitors may intensify the metabolisation of catecholamines in neurones by MAO, what may cause an enhanced generation of free radicals. This increase of free radicals may induce lipid peroxidation of membranes and therefore cause accelerated neuronal and glial cell death. For that reason we conclude, that centrally active COMT-inhibitors may only be used together with MAO-inhibitors in the neuroprotective treatment of neurodegenerative disorders. Medical treatment with both inhibitors will have to be performed very carefully due to cytotoxic effects of high catecholamine levels on neuronal and glial cells and due to possible prolongation or potentiation of the activity of several noradrenergic drugs in the periphery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Birkmayer W, Riederer P, Youdim MBH, Linauer W (1975) The potentiation of the antikinetic effect of L-Dopa treatment by an inhibitor of MAO-B, L-Deprenyl. J Neural Transm 36: 303–336

    Google Scholar 

  • Buu NT, Lussier C (1989) Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catecho-O-methyltransferase and phenolsulfotransferase. Prog Neuropsychopharmacol Biol Psychiatry 13 (3–4): 563–568

    Google Scholar 

  • Carman-Krzan M, Vige X, Wise BC (1991) Regulation of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J Neurochem 56 (2): 636–643

    Google Scholar 

  • Cedarbaum JM, Leger G, Guttman M (1991) Reduction of circulating 3-O-methyldopa by inhibition of catechol-O-methyltransferase with OR-611 and OR-462 in cynomologous monkeys: implications for the treatment of Parkinson's disease. Clin Neuropharmacol 14 (4): 330–342

    Google Scholar 

  • Chan BL, Chao MV, Saltiel AR (1989) Nerve growth factor stimulates the hydrolysis of glycosylphosphatidylinositol in PC-12 cells: a mechanism of protein kinase C regulation. Proc Natl Acad SCI USA 86 (6): 1756–1760

    Google Scholar 

  • Decker MW (1987) The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res Rev 12: 423–438

    Google Scholar 

  • Dexter DT, Carter CJ, Agid F, Lees AJ, Jenner P, Marsden CD (1987) Lipid peroxidation as the cause of nigral cell death in Parkinson's disease. Lancet ii: 639

    Google Scholar 

  • Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381–389

    Google Scholar 

  • Elizan TS, Yahr MD, Moros DA, Mendoza MR, Pang S, Bodian CA (1989) Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novi patients. Arch Neurol 46: 1275–1279

    Google Scholar 

  • Funakoshi H, Okuno S, Fujisawa H (1991) Different effects on activity caused by phosphorylation of tyrosine hydroxylase at serine 40 by three multifunctional protein kinases. J Biol Chem 266 (24): 15614–15620

    Google Scholar 

  • Furukawa S, Furukawa Y (1990 b) Nerve growth factor synthesis and its regulatory mechanisms: an approach to therapeutic induction of nerve growth factor synthesis. Cerebrovasc Brain Metab Rev 2 (4): 328–344

    Google Scholar 

  • Furukawa Y, Furukawa S, Satoyoshi E (1986) Catecholamines induce an increase in nerve growth factor content in the medium of mouse L-M cells. J Biol Chem 261 (13): 6039–6047

    Google Scholar 

  • Furukawa Y, Furukawa S, Satoyoshi E, Hayashi K (1989 a) Aliphatic side chain of catecholamine potentiates the stimulatory effect of the catechol part on the synthesis of nerve growth factor. FEBS 247: 463–467

    Google Scholar 

  • Furukawa S, Shinoda I, Furukawa Y (1989 b) Regulatory mechanism of nerve growth factor synthesis in vitro. Hum Cell 6, 2 (2): 137–142

    Google Scholar 

  • Furukawa Y, Fukazawa N, Miyama Y, Hayashi K, Furukawa S (1990 a) Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem Pharmacol 40 (10): 2337–2342

    Google Scholar 

  • Götz ME, Freyberger A, Riederer P (1990) Oxidative stress: a role in the pathogenesis of Parkinson's disease. J Neural Transm [Suppl 29]: 241–249

    Google Scholar 

  • Heikkila RE, Manzino L, Cabbat FS, Duvonisin RC (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine by mon-amino oxidase inhibitors. Nature 311: 467–469

    Google Scholar 

  • Hellweg R, Fischer W, Hock C, Gage FH, Björklund A, Thoenen H (1990) Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairment. Brain Res 537: 123–130

    Google Scholar 

  • Honnegger AM, Schmidt A, Ullrich A, Schlessinger J (1990) Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol Cell Biol 10 (8): 4035–4044

    Google Scholar 

  • Houchi H, Masserano JM, Bowyer JF, Weiner N (1990) Regulation of tyrosine hydroxylase activity in pheochromocytoma PC-12 cells by bradykinin. Mol Pharmacol 37 (1): 104–110

    Google Scholar 

  • Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350 (6315): 230–232

    Google Scholar 

  • Ishii A, Kiuchi K, Kobayashi R, Sumi M, Hidaka H, Nagatsu T (1991) A selective Ca2+/ calmodulin-dependent protein kinase II inhibitor, KN-62, inhibits the enhanced phosphorylation and the activation of tyrosine hydroxylase by 56 mM K+ in rat pheochromocytoma PC 12h cells. Biochem Biophys Res Commun 15; 176 (3): 1051–1056

    Google Scholar 

  • Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cutley L, Roberts TM (1987) Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositolkinase activity. Cell 50: 1021–1029

    Google Scholar 

  • Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DB, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neuro trophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88 (3): 961–965

    Google Scholar 

  • Langeloh A, Halbrugge T, Trendelenburg U (1991) Carrier-mediated outward transport of dopamine from adrenergic varicosties of the vas deferens of reserpine-pretreated rats. Naunyn Schmiedebergs Arch Pharmacol 344 (6): 619–622

    Google Scholar 

  • Langston JW, Irwin I, Langston EB, Forno LS (1984) Paragyline prevents 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine induced parkinsonism in primates. Science 225: 1480–1482

    Google Scholar 

  • Levi-Montalcini R (1987) The nerve growth factor 25 years later. Science 237: 1154–1162

    Google Scholar 

  • Laihinen A, Rinne JO, Rinne UK, Haaparanta M, Ruotsalinen U, Bergmann J, Solin O (1992) [18 F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462). Neurology 42 (1): 199–203

    Google Scholar 

  • Männisto PT, Ulmanen I, Lundström K, Taskinen J, Tenhunen J, Tilgmann C, Kaakkola S (1992) Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Drug Res 39: 291–350

    Google Scholar 

  • Margolis B, Bellot F, Honegger AM, Ulrich A, Schlessinger J, Ziberstein A (1990 a) Tyrosine kinase activity is essential for the association of phospholipase C gamma with EGF-receptor. Mol Cell Biol 10 (2): 435–441

    Google Scholar 

  • Margolis B, Zilberstein A, Franks C, Felder S, Kraemer S, Ullrich A, Rhee SG, Skorecki K, Schlessinger J (1990 b) Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis. Science 248 (4955): 607–610

    Google Scholar 

  • Matsui Y, Kumagae Y (1991) Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forbrain ischemia. Neurosci Lett 126 (2): 175–178

    Google Scholar 

  • Meyer M, Bandtlow C, Lindholm D, Heumann R, Thoenen H (1992) Regulation of the synthesis of nerve growth factor (NGF) by interleukin-1 (IL-1): facts and questions. In: Rothwell HJ, Dantzer RD (eds) Interleukin-1 in the brain. Pergamon Press, Oxford New York Seoul Tokyo, pp 173–186

    Google Scholar 

  • Mitchell JP, Hardie DG, Vulliet PR (1990) Site-specific phosphorylation of tyrosine hydroxylase after KCL depolarization and nerve growth factor treatment of PC 12 cells. J Biol Chem 265 (36): 22358–22564

    Google Scholar 

  • Molloy C, Battoro DP, Fleming TP, Marshall MS, Gibbs JB, Aaronson SA (1989) PDGF induction of tyrosine phosphorylation of GTPase activity protein. Nature 342: 711–714

    Google Scholar 

  • Nica Bhairid N, Goldberg R, Tipton KF (1990) Catechol-O-methyltransferase and its role in catecholamine metabolism. Adv Neurol 53: 489–495

    Google Scholar 

  • Oshima M, Sithanandam G, Rapp UR, Guroff G (1991) The phosphorylation and activation of B-raf in PC 12 cells stimulated by nerve growth factors. J Biol Chem 266 (35): 23753–23760

    Google Scholar 

  • Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 52: 515–521

    Google Scholar 

  • Rinne JO, Royarta M, Paljarvi L, Rummakainen J, Rinne UK (1991) Selegiline ‘deprenyl’ treatment and death nigral neurons in Parkinson's disease. Neurology 41 (6): 59–61

    Google Scholar 

  • Salo PT, Tatton WG (1992) Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res 31: (in press)

  • Sibley DR, Benovic JL, Caron MG, Levkowitz RJ (1987) Regulation of transmembrane signaling by receptor phosphorylation. Cell 48: 913–922

    Google Scholar 

  • Takeuchi R, Murase K, Furukawa Y, Furukawa S, Hayashi K (1990) Stimulation of nerve growth factor synthesis/secretion by 1,4-benzoquinone and its derivatives in cultured mouse astroglial cells. FEBS 261 (1): 63–66

    Google Scholar 

  • Tatton WG, Greenwood CE (1991) Rescue of dying neurons: a new reaction for deprenyl in MPTP parkinsonism. J Neurosci Res 30: 666–672

    Google Scholar 

  • Thoenen H, Edgar D (1985) Neurotrophic factors. Science 229: 238–242

    Google Scholar 

  • Thoenen H, Auburger G, Hellweg R, Heumann R, Korsching S (1987) Cholinergic innervation and levels of nerve growth factor and its mRNA in the central nervous system. In: Dowdall MJ, Hawthorne JN (eds) Cholinergic mechanisms, vol 6. Cellular and molecular basis of cholinergic function. Ellis Horwood, Cichester; VCA, Weinheim, pp 379–388

    Google Scholar 

  • Varticowski L, Druker B, Morrison D, Cantley L, Roberts T (1989) The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3-kinase. Nature 342: 699–702

    Google Scholar 

  • Volonte C, Greene LA (1990) Nerve growth factor (NGF) responses by non-neuronal cells: detection by assay of a novel NGF-activated protein kinase. Growth Factors 2 (4): 321–331

    Google Scholar 

  • Youdim MBH, Riederer P (1986) MAO type B: its relation to MPTP induced and classical parkinsonism. In: Markey SP, et al (eds) MPTP: a neurotoxin producing a Parkinsonism syndrome. Academic Press, New York, pp 203–218

    Google Scholar 

  • Züricher G, Keller HH, Kettler R, Borgulya J, Bonetti EP, Eigenmann R, Da Prada M (1990) Ro40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv Neurol 53: 497–503

    Google Scholar 

Download references

Author information

Author notes

  1. Th. Müller

    Present address: Department of Neurology, St. Josef-Hospital, University of Bochum, Federal Republic of Germany

Authors and Affiliations

  1. Department of Neurology, St. Josef-Hospital, University of Bochum, Federal Republic of Germany

    W. Kuhn & H. Przuntek

Authors
  1. Th. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Przuntek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, T., Kuhn, W. & Przuntek, H. Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?. J. Neural Transmission 92, 187–195 (1993). https://doi.org/10.1007/BF01244877

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244877

Keywords

Search

Navigation